Thursday, May 24, 2012
Login

Graceway Pharmaceuticals Announces Health Canada Has Approved PrVylomaTM (Imiquimod) Cream 3.75% for the Treatment of …

Graceway Pharmaceuticals Announces Health Canada Has Approved PrVylomaTM (Imiquimod) Cream 3.75% for the Treatment of …
TORONTO–(BUSINESS WIRE)–Graceway Pharmaceuticals Canada announced that Health Canada has approved Vyloma (imiquimod) Cream 3.75%, a topical prescription for the treatment of external genital warts (EGW) and perianal warts.

Via:Read more on Business Wire


Comments are closed.